Shunya Uchida

Shunya Uchida


Research Focus & Metrics

Academic Career Length

36Years (1991-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
13 April 2013 in Clinical and Experimental Nephrology
Verified
Journal Article
Closed access
PDF file
HYHirofumi Yano
Hirofumi Yano
YTYoshifuru Tamura
Yoshifuru Tamura
KKKana Kobayashi
Kana Kobayashi
MTMasayuki Tanemoto
Masayuki Tanemoto
SUShunya Uchida
Shunya Uchida

23 June 2016 in Clinical and Experimental Nephrology
Verified
Journal Article
Closed access
PDF file
TKTakanori Kumagai
Takanori Kumagai
TOTatsuru Ota
Tatsuru Ota
YTYoshifuru Tamura
Yoshifuru Tamura
WCWen Xiu Chang
Wen Xiu Chang
SSShigeru Shibata
Shigeru Shibata
SUShunya Uchida
Shunya Uchida

23 December 2015 in PLOS ONE
Verified
Journal Article
Open access
PDF file
SUShunya Uchida
Shunya Uchida
WCWen Xiu Chang
Wen Xiu Chang
TOTatsuru Ota
Tatsuru Ota
YTYoshifuru Tamura
Yoshifuru Tamura
TSTakeshi Shiraishi
Takeshi Shiraishi
SFShin Fujimori
Shin Fujimori
The role of uric acid (UA) in the progression of chronic kidney disease (CKD) remains controversial due to the unavoidable cause and result relationship. This study was aimed to clarify the independent impact of UA on the subsequent risk of end-stage renal disease (ESRD) by a propensity score analysis. A retrospective CKD cohort was used (n = 803). Baseline 23 covariates were subjected to a multivariate binary logistic regression with the targeted time-averaged UA of 6.0, 6.5 or 7.0 mg/dL. The participants trimmed 2.5 percentile from the extreme ends of the cohort underwent propensity score analyses consisting of matching, stratification on quintile and covariate adjustment. Covariate balances after 1:1 matching without replacement were tested for by paired analysis and standardized differences. A stratified Cox regression and a Cox regression adjusted for logit of propensity scores were examined. After propensity score matching, the higher UA showed elevated hazard ratios (HRs) by Kaplan-Meier analysis (≥6.0 mg/dL, HR 4.53, 95%CI 1.79–11.43; ≥6.5 mg/dL, HR 3.39, 95%CI 1.55–7.42; ≥7.0 mg/dL, HR 2.19, 95%CI 1.28–3.75). The number needed to treat was 8 to 9 over 5 years. A stratified Cox regression likewise showed significant crude HRs (≥6.0 mg/dL, HR 3.63, 95%CI 1.25–10.58; ≥6.5 mg/dL, HR 3.46, 95%CI 1.56–7.68; ≥7.0 mg/dL, HR 2.05, 95%CI 1.21–3.48). Adjusted HR lost its significance at 6.0 mg/dL. The adjustment for the logit of the propensity scores showed the similar results but with worse model fittings than the stratification method. Upon further adjustment for other covariates the significance was attained at 6.5 mg/dL. Three different methods of the propensity score analysis showed consistent results that the higher UA accelerates the progression to the subsequent ESRD. A stratified Cox regression outperforms other methods in generalizability and adjusting for residual bias. Serum UA should be targeted less than 6.5 mg/dL.

15 July 2015 in PLOS ONE
Verified
Journal Article
Open access
PDF file
WCWen Xiu Chang
Wen Xiu Chang
SAShinichiro Asakawa
Shinichiro Asakawa
DTDaigo Toyoki
Daigo Toyoki
YNYoshikazu Nemoto
Yoshikazu Nemoto
CMChikayuki Morimoto
Chikayuki Morimoto
SUShunya Uchida
Shunya Uchida
A goal of searching risk factors for chronic kidney disease (CKD) is to halt progressing to end-stage renal disease (ESRD) by potential intervention. To predict the future ESRD, 30% decline in estimated GFR over 2 years was examined in comparison with other time-dependent predictors. CKD patients who had measurement of serum creatinine at baseline and 2 years were enrolled (n = 701) and followed up to 6 years. Time-dependent parameters were calculated as time-averaged values over 2 years by a trapezoidal rule. Risk factors affecting the incidence of ESRD were investigated by the extended Cox proportional hazard model with baseline dataset and 2-year time-averaged dataset. Predictive significance of 30% decline in estimated GFR over 2 years for ESRD was analyzed. For predicting ESRD, baseline estimated GFR and proteinuria were the most influential risk factors either with the baseline dataset or the 2-year time-averaged dataset. Using the 2-year time-averaged dataset, 30% decline in estimated GFR over 2 years by itself showed the highest HR of 31.6 for ESRD whereas addition of baseline estimated GFR, proteinuria, serum albumin and hemoglobin yielded a better model by a multivariate Cox regression model. This novel surrogate was mostly associated with time-averaged proteinuria over 2 years with the cut-off of ~1 g/g creatinine. These results suggest that decline in estimated GFR and proteinuria are the risk factors while serum albumin and hemoglobin are the protective factors by the time-to-event analysis. Future incidence of ESRD is best predicted by 30% decline in eGFR over 2 years that can be modified by intervention to proteinuria, hemoglobin, uric acid, phosphorus, blood pressure and use of renin-angiotensin system inhibitors in the follow-up of 2 years.

1 November 2016 in Biochemical and Biophysical Research Communications
Verified
Journal Article
Open access
KIKenichi Ishizawa
Kenichi Ishizawa
NXNing Xu
Ning Xu
JLJohannes Loffing
Johannes Loffing
RLRichard P. Lifton
Richard P. Lifton
TFToshiro Fujita
Toshiro Fujita
SSShigeru Shibata
Shigeru Shibata
Kelch-like 3 (KLHL3) is a component of an E3 ubiquitin ligase complex that regulates blood pressure by targeting With-No-Lysine (WNK) kinases for degradation. Mutations in KLHL3 cause constitutively increased renal salt reabsorption and impaired K+ secretion, resulting in hypertension and hyperkalemia. Although clinical studies have shown that dietary K+ intake affects blood pressure, the mechanisms have been obscure. In this study, we demonstrate that the KLHL3 ubiquitin ligase complex is involved in the low-K+-mediated activation of Na-Cl cotransporter (NCC) in the kidney. In the distal convoluted tubules of mice eating a low-K+ diet, we found increased KLHL3 phosphorylation at S433 (KLHL3S433-P), a modification that impairs WNK binding, and also reduced total KLHL3 levels. These changes are accompanied by the accumulation of the target substrate WNK4, and activation of the downstream kinases SPAK (STE20/SPS1-related proline-alanine-rich protein kinase) and OSR1 (oxidative stress-responsive 1), resulting in NCC phosphorylation and its accumulation at the plasma membrane. Increased phosphorylation of S433 was explained by increased levels of active, phosphorylated protein kinase C (but not protein kinase A), which directly phosphorylates S433. Moreover, in HEK cells expressing KLHL3 and WNK4, we showed that the activation of protein kinase C by phorbol 12-myristate 13-acetate induces KLHL3S433-P and increases WNK4 levels by abrogating its ubiquitination. These data demonstrate the role of KLHL3 in low-K+-mediated induction of NCC; this physiologic adaptation reduces distal electrogenic Na+ reabsorption, preventing further renal K+ loss but promoting increased blood pressure.

23 June 2015 in Clinical and Experimental Nephrology
Verified
Journal Article
Open access
PDF file
WCWen-Xiu Chang
Wen-Xiu Chang
SAShigeyuki Arai
Shigeyuki Arai
YTYoshifuru Tamura
Yoshifuru Tamura
TKTakanori Kumagai
Takanori Kumagai
TOTatsuru Ota
Tatsuru Ota
SUShunya Uchida
Shunya Uchida
Targeting the modifiable risk factors may help halt the progression of CKD, thus risk factor analysis is better performed using the parameters in the follow-up. This study aimed to examine the time-dependent risk factors for CKD progression using time-averaged values and to investigate the characteristics of rapid progression group.